@article{Alexander_J-2022_88540,
title = {COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study},
author = {Alexander, J. and Kennedy, N. and Ibraheim, H. and Anandabaskaran, S. and Saifuddin, A. and Castro Seoane, R. and Liu, Z. and Nice, R. and Bewshea, C. and D'Mello, A. and Constable, L. and Jones, G. and Balarajah, S. and Fiorentino, F. and Sebastian, S. and Irving, P. and Hicks, L. and Williams, H. and Kent, A. and Linger, R. and Parkes, M. and Kok, K. and Patel, K. and Teare, J. and Altmann, D. and Boyton, R. and Goodhand, J. and Hart, A. and Lees, C. and Ahmad, T. and Powell, N.},
month = {apr},
year = {2022},
abstract = {BACKGROUND: The effects that therapies for inflammatory bowel disease (IBD) have on immune responses to SARS-CoV-2 vaccination are not yet fully known. Therefore, we sought to determine whether COVID-19 vaccine-induced antibody responses were altered in patients with IBD on commonly used immunosuppressive drugs.},
pages = {342-352},
volume = {7},
issue = {4},
journal = {The Lancet Gastroenterology & Hepatology},
publisher = {Elsevier},
url = {https://doi.org/10.1016/S2468-1253(22)00005-X},
}
